serum circFoxO3a is a useful tool for predicting survival in SCC. CONCLUSION: Altogether, our findings demonstrated that serum circFoxO3a could serve as a potential novel noninvasive predictive prognostic biomarker and therapeutic target for SCC.
Serum Circular FoxO3a Serves as a Novel Prognostic Biomarker in Squamous Cervical Cancer.